Inimmune

Developing immunotherapies and vaccine adjuvants to improve human health

placeMissoula, Montana, United States calendar_todayFounded 2016 groups35 employees language inimmune.com

Registered entities

Innovation

6 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 497 times.

YearFilings
20191
20202
20212
20222
20232
20244
20254
20261

Social engagement

Social engagement: 2K social following, 9 posts in the last 12 months — above the industry median.

Investor mix

5 investors on record; lead investors include Two Bear Capital.

Investor typeCountShare
Venture capital240%
Accelerator & incubator120%
Other / undisclosed240%

Recent activity

24 Jun 2026
Event
BIO 2026
15 Jun 2026
Event
BIO 2026
2 Jun 2026
Event
BIO2026
Coming soon